Monte Rosa Therapeutics, Inc. (GLUE) Insider Trading
Over the last 3 months, GLUE insiders made 0 open-market buys and 13 sales, a net sale of -$2.0M (SEC Form 4). Over the last 6 months, 166 institutions increased and 104 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
13
Net (3m)
-$2.0M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price -31.2%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 17, 2026 | Warmuth Markusdirector, officer: President & CEO | Sell | 9,500 | $23.18 |
| Jul 16, 2026 | Champoux Jenniferofficer: Chief Operating Officer | Sell | 4,351 | $23.38 |
| Jul 16, 2026 | Champoux Jenniferofficer: Chief Operating Officer | Option | 4,351 | $3.98 |
| Jul 7, 2026 | Townson Sharonofficer: Chief Scientific Officer | Option | 6,000 | $6.14 |
| Jul 7, 2026 | Townson Sharonofficer: Chief Scientific Officer | Sell | 5,600 | $23.25 |
| Jul 7, 2026 | Townson Sharonofficer: Chief Scientific Officer | Sell | 400 | $24.13 |
| Jul 1, 2026 | Janku Filipofficer: Chief Medical Officer | Option | 5,407 | $13.41 |
| Jul 1, 2026 | Janku Filipofficer: Chief Medical Officer | Sell | 5,407 | $24.50 |
| Jun 30, 2026 | Manning Anthony M.director | Option | 10,000 | $4.16 |
| Jun 30, 2026 | Janku Filipofficer: Chief Medical Officer | Option | 6,000 | $7.56 |
| Jun 30, 2026 | Janku Filipofficer: Chief Medical Officer | Sell | 6,000 | $22.95 |
| Jun 30, 2026 | Manning Anthony M.director | Sell | 10,000 | $23.11 |
| Jun 25, 2026 | Champoux Jenniferofficer: Chief Operating Officer | Option | 2,175 | $3.98 |
| Jun 25, 2026 | Champoux Jenniferofficer: Chief Operating Officer | Sell | 2,175 | $20.00 |
| Jun 25, 2026 | Townson Sharonofficer: Chief Scientific Officer | Option | 3,000 | $6.14 |
| Jun 25, 2026 | Townson Sharonofficer: Chief Scientific Officer | Sell | 3,000 | $20.00 |
| Jun 25, 2026 | Janku Filipofficer: Chief Medical Officer | Option | 6,000 | $7.56 |
| Jun 25, 2026 | Janku Filipofficer: Chief Medical Officer | Sell | 11,845 | $20.22 |
| Jun 25, 2026 | Janku Filipofficer: Chief Medical Officer | Option | 30,000 | $7.56 |
| Jun 25, 2026 | Janku Filipofficer: Chief Medical Officer | Sell | 30,000 | $21.42 |
| Jun 18, 2026 | Champoux Jenniferofficer: Chief Operating Officer | Option | 2,176 | $3.98 |
| Jun 18, 2026 | Champoux Jenniferofficer: Chief Operating Officer | Sell | 2,176 | $19.00 |
| Jun 18, 2026 | Townson Sharonofficer: Chief Scientific Officer | Option | 3,000 | $6.14 |
| Jun 18, 2026 | Townson Sharonofficer: Chief Scientific Officer | Sell | 3,000 | $19.00 |
| Jun 12, 2026 | Siu Christinedirector | Grant | 25,800 | $17.10 |
| Jun 12, 2026 | SCHIFF ANDREW Ndirector | Grant | 25,800 | $17.10 |
| Jun 12, 2026 | Behbahani Alidirector | Grant | 25,800 | $17.10 |
| Jun 12, 2026 | Blackwell Kimberlydirector | Grant | 25,800 | $17.10 |
| Jun 12, 2026 | Hughes Eric Adirector | Grant | 25,800 | $17.10 |
| Jun 12, 2026 | Skvarka Jandirector | Grant | 25,800 | $17.10 |
Source: GLUE SEC Form 4 filings, latest Jul 17, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their GLUE positions over the last 6 months (SEC Form 13F).
Increased
166
New positions
81
Reduced
104
Sold out
24
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 8.9M | Aug 14, 2026 |
| NEA MANAGEMENT COMPANY, LLC | Unchanged | 7.7M | May 15, 2026 |
| NEA Management Company, LLC | Unchanged | 7.7M | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 6.8M | Aug 7, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 6.7M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 5.6M | May 13, 2026 |
| TCG CROSSOVER MANAGEMENT, LLC | Unchanged | 4.6M | May 15, 2026 |
| TCG Crossover Management, LLC | Unchanged | 4.6M | Aug 14, 2026 |
| Vestal Point Capital, LP | Increased | 4.6M | Aug 14, 2026 |
| BVF INC/IL | Increased | 4.5M | May 15, 2026 |
| BVF INC/IL | Unchanged | 4.5M | Aug 14, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 4.3M | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 4.3M | Aug 14, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 4.2M | May 15, 2026 |
| STATE STREET CORP | Increased | 3.7M | Aug 7, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.